1. Precision BioSciences Strengthens Board of Directors with Appointment of Geno Germano

    Precision BioSciences Strengthens Board of Directors with Appointment of Geno Germano

    DURHAM, N.C., March 11, 2020 (GLOBE NEWSWIRE) -- Precision BioSciences Inc. (Nasdaq: DTIL), a life sciences company dedicated to improving life through the application of its pioneering, proprietary ARCUS® genome editing platform, announced today that Geno Germano, President and CEO of Elucida Oncology, has been appointed to the company’s Board of Directors...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Topics Mentioned